7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Evofem Biosciences, Inc
(NASDAQ:EVFM) 

EVFM stock logo

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EV...

Founded: 2007
Full Time Employees: 147 (May 2021)
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Evofem Biosciences Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0176.97353.93530.9707.87884.831,061.81,238.77
Evofem Biosciences Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 048.0396.07144.1192.13240.17288.2336.23
Evofem Biosciences Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 063.53127.06190.58254.11317.64381.17444.7
Evofem Biosciences Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.91-3.36-2.8-2.24-1.68-1.12-0.560
Evofem Biosciences Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.95-3.38-2.82-2.26-1.69-1.13-0.56-0
Evofem Biosciences Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.040.070.180.290.40.510.620.73
Evofem Biosciences P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 09.3418.6828.0237.3646.756.0465.39
Evofem Biosciences (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -14.35-12.3-10.25-8.2-6.15-4.1-2.050
Evofem Biosciences P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -15.33-13.14-10.95-8.76-6.57-4.38-2.19-0
No extra charts and metrics for this ticker.